$FZMD
Fuse Medical, Inc.

2023 Q1 Form 10-K Financial Statement

#000156459023005716 Filed on April 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $3.984M $4.886M $18.64M
YoY Change -12.51% -19.35% -8.67%
Cost Of Revenue $1.168M $2.273M $7.103M
YoY Change -28.11% -10.65% -16.22%
Gross Profit $2.816M $2.613M $11.54M
YoY Change -3.86% -25.65% -3.3%
Gross Profit Margin 70.68% 53.48% 61.9%
Selling, General & Admin $1.706M $3.190M $6.537M
YoY Change -46.93% -23.18% -53.52%
% of Gross Profit 60.59% 122.07% 56.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $33.43K -$88.84K $137.4K
YoY Change -39.36% -525.28% 103.14%
% of Gross Profit 1.19% -3.4% 1.19%
Operating Expenses $2.982M $3.101M $12.36M
YoY Change -8.25% -25.69% -12.56%
Operating Profit -$165.6K -$487.9K -$815.1K
YoY Change -48.33% -25.92% -62.88%
Interest Expense $57.19K -$54.82K $171.3K
YoY Change -273.52% 78.74% -318.96%
% of Operating Profit
Other Income/Expense, Net -$57.19K $4.108M $3.937M
YoY Change 73.53% 1100.61% 1050.55%
Pretax Income -$222.8K $3.565M $3.122M
YoY Change -36.97% -1127.36% -298.82%
Income Tax $5.592K $6.350K $23.66K
% Of Pretax Income 0.18% 0.76%
Net Earnings -$228.4K $3.559M $3.098M
YoY Change -36.26% -1110.96% -295.11%
Net Earnings / Revenue -5.73% 72.85% 16.62%
Basic Earnings Per Share $0.00 $0.04
Diluted Earnings Per Share $0.00 $0.04 $0.04
COMMON SHARES
Basic Shares Outstanding 73.90M 72.90M 70.32M
Diluted Shares Outstanding 70.32M 77.86M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $211.0K $147.9K $147.9K
YoY Change -59.62% -73.27% -73.27%
Cash & Equivalents $211.0K $147.9K $147.9K
Short-Term Investments
Other Short-Term Assets $116.1K $126.0K $126.0K
YoY Change 20.97% 2028.72% 2028.72%
Inventory $9.154M $9.495M $9.495M
Prepaid Expenses
Receivables $2.761M $3.997M $3.997M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.24M $13.77M $13.77M
YoY Change 1.61% 7.33% 7.33%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $709.00 $710.00
YoY Change -100.0% -90.22% -90.21%
Goodwill $1.973M $1.973M
YoY Change 0.0% 0.0%
Intangibles $1.158M $1.191M
YoY Change -10.15% -9.59%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.192M $5.997M $5.997M
YoY Change 8.11% 9.44% 9.44%
TOTAL ASSETS
Total Short-Term Assets $12.24M $13.77M $13.77M
Total Long-Term Assets $6.192M $5.997M $5.997M
Total Assets $18.43M $19.76M $19.76M
YoY Change 3.71% 7.97% 7.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.551M $5.700M $5.700M
YoY Change -0.42% 27.76% 27.76%
Accrued Expenses $4.856M $4.540M $4.540M
YoY Change 55.4% 56.67% 56.67%
Deferred Revenue
YoY Change
Short-Term Debt $1.879M $2.147M $2.147M
YoY Change -8.88% -16.87% -16.87%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.29M $12.39M $12.39M
YoY Change 15.67% 22.14% 24.59%
LONG-TERM LIABILITIES
Long-Term Debt $200.0K $200.0K $200.0K
YoY Change 0.0% 0.0% 0.0%
Other Long-Term Liabilities $7.486M $7.486M $7.486M
YoY Change -35.43% -35.43% -35.43%
Total Long-Term Liabilities $7.686M $7.686M $7.686M
YoY Change -34.83% -34.83% -34.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.29M $12.39M $12.39M
Total Long-Term Liabilities $7.686M $7.686M $7.686M
Total Liabilities $18.97M $20.07M $20.07M
YoY Change -11.97% -7.65% -7.65%
SHAREHOLDERS EQUITY
Retained Earnings -$2.746M -$2.518M
YoY Change -55.16%
Common Stock $2.207M $2.207M
YoY Change 1.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$539.2K -$310.9K -$310.9K
YoY Change
Total Liabilities & Shareholders Equity $18.43M $19.76M $19.76M
YoY Change 3.71% 7.97% 7.97%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$228.4K $3.559M $3.098M
YoY Change -36.26% -1110.96% -295.11%
Depreciation, Depletion And Amortization $33.43K -$88.84K $137.4K
YoY Change -39.36% -525.28% 103.14%
Cash From Operating Activities $331.0K -$831.5K $34.80K
YoY Change -47.71% -58.63% -101.96%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$520.8K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $520.8K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -267.8K -47.48K -440.1K
YoY Change -48.97% -105.95% -138.47%
NET CHANGE
Cash From Operating Activities 331.0K -831.5K 34.80K
Cash From Investing Activities 0.000 520.8K 0.000
Cash From Financing Activities -267.8K -47.48K -440.1K
Net Change In Cash 63.14K -358.2K -405.3K
YoY Change -305.61% -70.45% -36.09%
FREE CASH FLOW
Cash From Operating Activities $331.0K -$831.5K $34.80K
Capital Expenditures $0.00 -$520.8K $0.00
Free Cash Flow $331.0K -$310.7K $34.80K
YoY Change -57.12% -84.54% -101.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11593832
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11936000
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
594536
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20249
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19540
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12998
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
709
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7251
CY2022 us-gaap Depreciation
Depreciation
6542
CY2021 us-gaap Depreciation
Depreciation
10540
CY2022 dei Auditor Firm
AuditorFirmId
2738
CY2022 dei Auditor Name
AuditorName
M&K CPAS
CY2022 dei Auditor Location
AuditorLocation
Houston, TX, US
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147854
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
553190
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3996860
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3528992
CY2022Q4 us-gaap Inventory Net
InventoryNet
9494506
CY2021Q4 us-gaap Inventory Net
InventoryNet
8736474
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
126022
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5921
CY2022Q4 us-gaap Assets Current
AssetsCurrent
13765242
CY2021Q4 us-gaap Assets Current
AssetsCurrent
12824577
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
709
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7251
CY2022Q4 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
2832764
CY2021Q4 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
2182437
CY2022 dei Entity File Number
EntityFileNumber
000-10093
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-1224913
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
1565 N. Central Expressway
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 220
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Richardson
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75080
CY2022 dei City Area Code
CityAreaCode
469
CY2022 dei Local Phone Number
LocalPhoneNumber
862-3030
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
73895794
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1190980
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1317341
CY2022Q4 us-gaap Goodwill
Goodwill
1972886
CY2021Q4 us-gaap Goodwill
Goodwill
1972886
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
67638
CY2021 fzmd Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
342168
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
257913
CY2021 fzmd Provision For Discounts On Long Term Accounts Receivable
ProvisionForDiscountsOnLongTermAccountsReceivable
739559
CY2021 fzmd Provision For Bad Debts And Discounts
ProvisionForBadDebtsAndDiscounts
-289505
CY2021 fzmd Provision For Slow Moving And Obsolete Inventory
ProvisionForSlowMovingAndObsoleteInventory
-586545
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1188408
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1168516
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Liabilities
Liabilities
20073435
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73895794
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1225049
CY2022Q4 fzmd Allowance For Inventories Current
AllowanceForInventoriesCurrent
1778173
CY2022Q4 fzmd Allowance For Long Term Receivable Non Current
AllowanceForLongTermReceivableNonCurrent
4330883
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73895794
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-18282
CY2021 fzmd Increase Decrease In Long Term Accounts Receivable
IncreaseDecreaseInLongTermAccountsReceivable
1252486
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-310854
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19762581
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18644784
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20414268
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1471042
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
120101
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1642298
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34799
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
738958
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1468274
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
7103033
CY2022 fzmd Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
4108134
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23655
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3098113
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77860418
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70321566
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
190817
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M23D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M23D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y8M23D
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Security12b Title
Security12bTitle
Common Stock
CY2022 dei Trading Symbol
TradingSymbol
FZMD
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
1030536
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
290500
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
498261
CY2021Q4 fzmd Allowance For Inventories Current
AllowanceForInventoriesCurrent
2491183
CY2021Q4 fzmd Allowance For Long Term Receivable Non Current
AllowanceForLongTermReceivableNonCurrent
3355391
CY2022Q4 us-gaap Assets
Assets
19762581
CY2021Q4 us-gaap Assets
Assets
18304492
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5700236
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4461641
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4540366
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2898068
CY2022Q4 fzmd Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
150000
CY2021Q4 fzmd Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
150000
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1997135
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2432770
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12387737
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9942479
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
200000
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
200000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
7485698
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11593832
CY2021Q4 us-gaap Liabilities
Liabilities
21736311
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72895793
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72895793
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
728958
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1455422
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2518086
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5616199
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3431819
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18304492
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
8478561
CY2022 us-gaap Gross Profit
GrossProfit
11541751
CY2021 us-gaap Gross Profit
GrossProfit
11935707
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6537382
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7013297
CY2022 fzmd Commissions
Commissions
5682038
CY2021 fzmd Commissions
Commissions
7050278
CY2022 fzmd Depreciation Depletion And Amortization Excluding Cost Of Revenue
DepreciationDepletionAndAmortizationExcludingCostOfRevenue
137403
CY2021 fzmd Depreciation Depletion And Amortization Excluding Cost Of Revenue
DepreciationDepletionAndAmortizationExcludingCostOfRevenue
67638
CY2022 us-gaap Operating Expenses
OperatingExpenses
12356823
CY2021 us-gaap Operating Expenses
OperatingExpenses
14131213
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-815072
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-2195506
CY2021 fzmd Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
342168
CY2021 fzmd Gain Loss On Payroll Protection Program Loans Extinguishment
GainLossOnPayrollProtectionProgramLoansExtinguishment
361400
CY2022 us-gaap Interest Expense
InterestExpense
171294
CY2021 us-gaap Interest Expense
InterestExpense
78230
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3936840
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
625338
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3121768
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1570168
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17723
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1587891
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70321566
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70321566
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-2112841
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
257913
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1587891
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3431819
CY2022 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
22852
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3098113
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-310854
CY2022 us-gaap Profit Loss
ProfitLoss
3098113
CY2021 us-gaap Profit Loss
ProfitLoss
-1587891
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
137403
CY2022 fzmd Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
4108134
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
22852
CY2022 fzmd Provision For Discounts On Long Term Accounts Receivable
ProvisionForDiscountsOnLongTermAccountsReceivable
975489
CY2022 fzmd Provision For Bad Debts And Discounts
ProvisionForBadDebtsAndDiscounts
-207761
CY2022 fzmd Provision For Slow Moving And Obsolete Inventory
ProvisionForSlowMovingAndObsoleteInventory
713010
CY2021 fzmd Gain Loss On Payroll Protection Program Loan Extinguishment
GainLossOnPayrollProtectionProgramLoanExtinguishment
361400
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
260107
CY2022 fzmd Increase Decrease In Long Term Accounts Receivable
IncreaseDecreaseInLongTermAccountsReceivable
1625816
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1238595
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
313334
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1778328
CY2021 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-913352
CY2022 fzmd Net Payment Proceeds On Senior Secured Revolving Credit Facility
NetPaymentProceedsOnSeniorSecuredRevolvingCreditFacility
-435635
CY2021 fzmd Net Payment Proceeds On Senior Secured Revolving Credit Facility
NetPaymentProceedsOnSeniorSecuredRevolvingCreditFacility
2432770
CY2022 fzmd Payments For Senior Secured Revolving Credit Facility
PaymentsForSeniorSecuredRevolvingCreditFacility
4500
CY2021 fzmd Payments For Senior Secured Revolving Credit Facility
PaymentsForSeniorSecuredRevolvingCreditFacility
236358
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-440135
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1144060
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-405336
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-634268
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
553190
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1187458
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
147854
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
553190
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18052
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19581
CY2022 us-gaap Interest Paid Net
InterestPaidNet
160447
CY2021 us-gaap Interest Paid Net
InterestPaidNet
42830
CY2022 fzmd Percentage Of Common Stock Issued
PercentageOfCommonStockIssued
0.614
CY2022 fzmd Percentage Of Common Stock Outstanding
PercentageOfCommonStockOutstanding
0.614
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in accordance with generally accepted accounting principles in the United States of America (GAAP), requires the Company’s management to make estimates and assumptions that affect the Company’s reported amounts in the consolidated financial statements.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Actual results could differ from those estimates. Significant estimates on the accompanying consolidated financial statements include the allowances for doubtful accounts, valuation of inventories, the Company’s effective income tax rate and the fair value calculations of stock-based compensation, goodwill, finite lived intangibles and the earn-out liability. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p>
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassification</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long term accounts receivable, net of allowance was previously reported as a component of current assets as accounts receivable, net of allowance, in the Company’s accompanying consolidated balance sheets. Long term accounts receivable reflects Cases where the patient has obtained a letter of protection, (“LOP”). A LOP is a contract that provides that the medical providers will be paid from any proceeds received from settlement of litigation of the underlying cause of action with respect to the event that necessitated medical goods and services. Once the medical provider receives payment, then the medical provider pays the Company’s invoice, which payment is generally greater than 365 days from date of service. The LOP provides medical providers with greater certainty of full payment. This reclassification had no effect on the previously reported total assets or net loss.   </p>
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-4108134
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
7485698
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-342168
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11593832
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1501057
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18644784
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20414268
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1496557
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
310077
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
179216
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1190980
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1317341
CY2022Q4 us-gaap Goodwill
Goodwill
1972886
CY2021Q4 us-gaap Goodwill
Goodwill
1972886
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
130861
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
57097
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2021Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2021Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20249
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
130862
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
124166
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
50532
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
50530
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
50520
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
79990
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
486600
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
27503
CY2021 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
27501
CY2021Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
2246892
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2246892
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2246892
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1816546
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
212104
CY2022 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-12-31
CY2022 fzmd Operating Lease Requires Monthly Payments
OperatingLeaseRequiresMonthlyPayments
14000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7777
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
749
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8526
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1745000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.86
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1745000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.86
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1745000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.86
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
212104
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
430346
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2458996
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2458996
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2246892
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
23655
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
17723
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
23655
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
17723
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
0
CY2021 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23655
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17723
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1632301
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1632301
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1262269
CY2022Q4 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
61005
CY2022Q4 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
61005
CY2021Q4 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
104635
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
560735
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
560735
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
555936
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
369456
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
369456
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
523131
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
26465
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
26465
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1244
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2649962
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2649962
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2447215
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
190817
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
198801
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
149
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
149
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1522
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
190966
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
190966
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
200323
CY2022Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
2458996
CY2022Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
2458996
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
212104
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2458996
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7772862
CY2022 fzmd Net Operating Loss Carryforwards Earliest Expiration Year
NetOperatingLossCarryforwardsEarliestExpirationYear
2022
CY2022 fzmd Net Operating Loss Carryforwards Latest Expiration Year
NetOperatingLossCarryforwardsLatestExpirationYear
2038
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 fzmd Effective Income Tax Rate Reconciliation Gain On Paycheck Protection Loan
EffectiveIncomeTaxRateReconciliationGainOnPaycheckProtectionLoan
0.000
CY2021 fzmd Effective Income Tax Rate Reconciliation Gain On Paycheck Protection Loan
EffectiveIncomeTaxRateReconciliationGainOnPaycheckProtectionLoan
0.045
CY2022 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.276
CY2021 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.000
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.006
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.008
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.068
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.258
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.008
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.011
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.008
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.011
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
248618

Files In Submission

Name View Source Status
0001564590-23-005716-index-headers.html Edgar Link pending
0001564590-23-005716-index.html Edgar Link pending
0001564590-23-005716.txt Edgar Link pending
0001564590-23-005716-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fzmd-10k_20221231.htm Edgar Link pending
fzmd-20221231.xsd Edgar Link pending
fzmd-ex1046_107.htm Edgar Link pending
fzmd-ex1047_12.htm Edgar Link pending
fzmd-ex1048_10.htm Edgar Link pending
fzmd-ex211_9.htm Edgar Link pending
fzmd-ex231_11.htm Edgar Link pending
fzmd-ex232_418.htm Edgar Link pending
fzmd-ex311_8.htm Edgar Link pending
fzmd-ex312_7.htm Edgar Link pending
fzmd-ex321_6.htm Edgar Link pending
g5busli5sjkj000001.jpg Edgar Link pending
gecpdpp5mr54000001.jpg Edgar Link pending
fzmd-20221231_def.xml Edgar Link unprocessable
fzmd-20221231_lab.xml Edgar Link unprocessable
fzmd-20221231_pre.xml Edgar Link unprocessable
fzmd-10k_20221231_htm.xml Edgar Link completed
ggmm1lfi2lmj000001.jpg Edgar Link pending
ggmm1lfi2lmj000002.jpg Edgar Link pending
gmrwwxxaxtoj000001.jpg Edgar Link pending
gtwibcrdypvd000001.jpg Edgar Link pending
gtwibcrdypvd000002.jpg Edgar Link pending
gtwibcrdypvd000003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fzmd-20221231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable